Regeneron Pharmaceuticals, inc.
Proposal 1.1
Election of Director: Arthur F. Ryan
Caisse vote:
Against
Applicable policy or principle:
PR_05_01
Proposal 1.2
Election of Director: George L. Sing
Caisse vote:
Against
Applicable policy or principle:
PR_05_01
Proposal 1.3
Election of Director: Marc Tessier-Lavigne
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 2.
Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2018.
Caisse vote:
For
Applicable policy or principle:
PR_06